🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study of itacitinib (INCB039110) in patients with myelofibrosis. ...
Status
Completed
Location
Birmingham Hematology Oncology Associates, LLC
Start Date
2012-07-16
Trial ID
NCT01633372
Treatments Being Tested
To determine if Itacitinib in combination with corticosteroids is safe and ...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02614612
Treatments Being Tested
The study's primary objective is designed to assess the safety and tolerabi...
Status
Terminated
Location
Columbia University Irving Medical Center
Start Date
2020-01-20
Trial ID
NCT04070781
Treatments Being Tested
This is a study evaluating a 28-day course followed by a 56-day course of i...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01626573
Treatments Being Tested
In this trial, the investigators will begin to explore the possibility that...
Status
Completed
Location
Washington University School of Medicine
Start Date
2019-09-04
Trial ID
NCT03755414
"The purpose of this study is to assess the safety and efficacy of oral adm...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2020-02-07
Trial ID
NCT04071366
Treatments Being Tested
This research is being done to learn whether drug called itacitinib, which ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2023-07-06
Trial ID
NCT05823571
Treatments Being Tested
The purpose of this study is to determine whether itacitinib is safe and ef...
Status
Recruiting
Location
CH Amiens
Start Date
2023-02-02
Trial ID
NCT04789850
Treatments Being Tested
This project aims to test the effectiveness of ITACITINIB in sporadic Hemop...
Status
Completed
Location
Hôpital Avicenne
Start Date
2022-05-03
Trial ID
NCT05063110
Treatments Being Tested
This is a study of itacitinib in patients with chronic plaque psoriasis. Th...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01634087
Treatments Being Tested